Provided by Tiger Trade Technology Pte. Ltd.

Theravance Biopharma

17.03
+0.02000.12%
Post-market: 17.030.00000.00%16:10 EDT
Volume:332.38K
Turnover:5.66M
Market Cap:882.64M
PE:16.30
High:17.07
Open:17.02
Low:17.00
Close:17.01
52wk High:21.03
52wk Low:13.08
Shares:51.83M
Float Shares:25.78M
Volume Ratio:0.89
T/O Rate:1.29%
Dividend:- -
Dividend Rate:- -
EPS(TTM):1.05
EPS(LYR):2.06
ROE:20.91%
ROA:1.33%
PB:3.05
PE(LYR):8.27

Loading ...

Ireland's Theravance Biopharma Q4 revenue misses expectations

Reuters
·
Mar 19

Theravance Biopharma Q4 Operating Income USD 20.012 Million

Reuters
·
Mar 19

Theravance Biopharma Q4 EPS $1.15 Beats $1.02 Estimate, Sales $45.891M Miss $50.793M Estimate

Benzinga Earnings
·
Mar 19

Theravance Biopharma reports Q4 EPS $1.15, consensus $1.10

TIPRANKS
·
Mar 19

Theravance Biopharma Q4 EPS USD 1.15

THOMSON REUTERS
·
Mar 19

Corrected-Theravance Biopharma Q4 Revenue USD 45.9 Million VS. Ibes Estimate USD 58.5 Million (Corrects Amount)

THOMSON REUTERS
·
Mar 19

Theravance Biopharma Q4 Adjusted Net Income USD 3.131 Million VS. Ibes Estimate USD 58.3 Million

THOMSON REUTERS
·
Mar 19

Corrected-Theravance Biopharma Q4 Adjusted Net Income USD 3.131 Million (Removes Reference to Estimate)

THOMSON REUTERS
·
Mar 19

Theravance Biopharma SVP, Comm & Medical Affairs Rhonda Farnum disposes of USD 432,167 in common shares

Reuters
·
Mar 19

Theravance Biopharma options imply 3.2% move in share price post-earnings

TIPRANKS
·
Mar 06

Theravance Biopharma downgraded at Oppenheimer after ampreloxetine miss

TIPRANKS
·
Mar 05

B. Riley Downgrades Theravance Biopharma to Neutral From Buy, Adjusts Price Target to $14 From $28

MT Newswires Live
·
Mar 04

Theravance Biopharma Inc : Btig Cuts Target Price to $21 From $40

THOMSON REUTERS
·
Mar 04

Theravance Biopharma Down Nearly 27%, On Pace for Largest Percent Decrease Since August 2021 -- Data Talk

Dow Jones
·
Mar 04

Top Midday Decliners

MT Newswires Live
·
Mar 04

BUZZ-U.S. STOCKS ON THE MOVE-Versant Media Group, Lithium miners, Expedia Group

Reuters
·
Mar 04

Theravance Biopharma Plummets As Phase 3 Study Falls Short

Benzinga
·
Mar 04

Theravance Biopharma Is Maintained at Buy by BTIG

Dow Jones
·
Mar 04

Theravance Biopharma price target lowered to $21 from $40 at BTIG

TIPRANKS
·
Mar 04

BUZZ-U.S. STOCKS ON THE MOVE-Expedia Group, Blue Owl Capital, Enphase Energy

Reuters
·
Mar 03